ToxoTech is a research development biopharmaceutical company that uses expert knowledge in structural biology to design and develop novel toxin-based biological products for the treatment of  neuromuscular and neurological disorders.


The botulinum neurotoxins are clinically proven molecules that have been used for decades to treat an increasing range of medical conditions. ToxoTech developed a unique, patented technology based on a modified botulinum neurotoxin with enhanced receptor interactions that displays improved pharmacological properties.